Related Experiment Video
Updated: Aug 31, 2025
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Identifying mutant-specific multi-drug combinations using comparative network reconstruction
Evert Bosdriesz1, João M Fernandes Neto2, Anja Sieber3,4
1Bioinformatics, Computer Science, VU Amsterdam, De Boelelaan 1111, Amsterdam 1081 HV, the Netherlands.
Abstract:
Targeted inhibition of aberrant signaling is an important treatment strategy in cancer, but responses are often short-lived. Multi-drug combinations have the potential to mitigate this, but to avoid toxicity such combinations must be selective and given at low dosages. Here, we present a pipeline to identify promising multi-drug combinations. We perturbed an isogenic PI3K mutant and wild-type cell line pair with a limited set of drugs and recorded their signaling state and cell viability. We then reconstructed their signaling networks and mapped the signaling response to changes in cell viability. The resulting models, which allowed us to predict the effect of unseen combinations, indicated that no combination selectively reduces the viability of the PI3K mutant cells. However, we were able to validate 25 of the 30 combinations that we predicted to be anti-selective. Our pipeline enables efficient prioritization of multi-drug combinations from the enormous search space of possible combinations.
Insights
Developing new cancer treatments, this study introduces a pipeline to find effective, low-dose multi-drug combinations. The research identified anti-selective combinations, improving drug discovery for targeted cancer therapy.
Area of Science:
- Oncology
- Pharmacology
- Systems Biology
Background:
- Targeted cancer therapies inhibiting aberrant signaling pathways are crucial but often face limited response duration.
- Multi-drug combinations offer potential to overcome resistance and improve efficacy, but require careful selection to minimize toxicity.
- Identifying optimal drug combinations necessitates understanding complex cellular signaling networks and their impact on cell viability.
Purpose of the Study:
- To develop and validate a computational pipeline for identifying promising multi-drug combinations for cancer treatment.
- To predict the effects of drug combinations on cancer cell viability based on reconstructed signaling networks.
- To assess the selectivity and efficacy of drug combinations in PI3K-mutant versus wild-type cancer cells.
Main Methods:
- Perturbation of isogenic PI3K mutant and wild-type cell lines with a defined drug set.
- Measurement of cellular signaling states and cell viability following drug treatment.
- Reconstruction of cellular signaling networks and modeling of signaling response to cell viability.
- Prediction and experimental validation of multi-drug combination effects.
Main Results:
- The developed models predicted that no tested combination selectively reduced the viability of PI3K mutant cells.
- Twenty-five out of thirty predicted anti-selective combinations were experimentally validated.
- The pipeline demonstrated efficiency in prioritizing multi-drug combinations from a large search space.
Conclusions:
- The computational pipeline enables efficient identification and prioritization of potential multi-drug combinations for cancer therapy.
- While no combination showed selective anti-mutant activity, the validation of anti-selective effects highlights the pipeline's predictive power.
- This approach aids in navigating the vast landscape of drug combinations to find therapeutically relevant strategies.
More Related Videos
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
Related Concept Videos
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...